Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Return of Individual Genomic Results to Germline Pathogenic Variant Carriers of Hereditary Cancer in Population Based Cohort Study].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Mar 2024

Ohneda Kinuko

Abstract excerpt

Return of individual genomic results(ROGR)to participants in population-based biobank has been rarely conducted in research settings, and the procedure of ROGR performed in foreign countries may not be simply applied to Japanese participants, because of the difference in social background. The Tohoku Medical Megabank Project, which was launched in 2012 aiming to build a foundation of personalized genomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Germ Cells

Share to Hereditary Breast and Ovarian Cancer Syndrome

Source

Identifiers

PMID: 38494798

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Return of Individual Genomic Results to Germline Pathogenic Variant Carriers of Hereditary Cancer in Population Based Cohort Study].PMID 38494798Read ↗

Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants.Semantic proximity Read ↗

Personalized medicine with germline pathogenic variants: Importance of population- and region-wide evidence.Semantic proximity Read ↗

Identification of actionable genetic variants in 4,198 Scottish volunteers from the Viking Genes research cohort and implementation of return of resultsSemantic proximity Read ↗

[Hereditary Tumor Medical Care in the Age of Cancer Genomic Medicine].Semantic proximity Read ↗

Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond <em>BRCA1/2</em>Semantic proximity Read ↗

Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility.Semantic proximity Read ↗

Actionable genetic variants in 4,198 Scottish participants from the Orkney and Shetland founder populations and implementation of return of results.Semantic proximity Read ↗

From the patient to the population: Use of genomics for population screeningSemantic proximity Read ↗

The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy SubjectsSemantic proximity Read ↗

Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records.Semantic proximity Read ↗

Whole genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the <i>All of Us</i> Research ProgramSemantic proximity Read ↗

Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New NormalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.